# Herpes Simplex Virus Type 2 (HSV-2) Suppression to Prevent HIV Transmission

> **NCT00194519** · PHASE3 · COMPLETED · sponsor: **University of Washington** · enrollment: 3408 (actual)

## Conditions studied

- HIV Infection
- Herpes Simplex, Genital
- Sexually Transmitted Diseases

## Interventions

- **DRUG:** Generic acyclovir
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00194519
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** 2009-11
- **Final completion:** 2010-03
- **Target enrollment:** 3408 (ACTUAL)
- **Last updated:** 2018-10-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00194519

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00194519, "Herpes Simplex Virus Type 2 (HSV-2) Suppression to Prevent HIV Transmission". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00194519. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*